Centra Medrin 40 mg Suspension is a Health Canada–registered veterinary drug (DIN 00517097) held by Central Sales Limited, containing Methylprednisolone Acetate. Health Canada lists its status as Cancelled Post Market (status date 25 Jul 2003). Nexara Health has matched 535 registrations of Methylprednisolone Acetate across 33 other regulated markets.

Health Canada registration

Methylprednisolone Acetate registered in other markets

535 registrations of the same molecule in 33 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Methylprednisolone Acetate worldwide →

Regulator price references for Methylprednisolone Acetate

Published list or reimbursement prices for Methylprednisolone Acetate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Centra Medrin (DIN 00517097) marketed in Canada?

No. Health Canada lists DIN 00517097 as Cancelled Post Market as of 25 Jul 2003.

Who holds the Canadian licence for this product?

Central Sales Limited is the company of record in the Health Canada Drug Product Database.

Is Methylprednisolone Acetate registered outside Canada?

Yes — Nexara Health has matched 535 registrations in 33 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00517097, status date 2003-07-25; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00517097, status date 2003-07-25; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 00517097, status date 2003-07-25; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.